ETHRIL 250 (ERYTHROMYCIN STEARATE) — FDA Approval ANDA061605 (BRISTOL MYERS SQUIBB)
ETHRIL 250 (ERYTHROMYCIN STEARATE) — FDA Approval ANDA061605 (BRISTOL MYERS SQUIBB) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ETHRIL 250; Active ingredients: ERYTHROMYCIN STEARATE; Application number: ANDA061605.
| Brand name | ETHRIL 250 |
|---|---|
| Active ingredients | ERYTHROMYCIN STEARATE |
| Application number | ANDA061605 |
| Sponsor | BRISTOL MYERS SQUIBB |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →